Transforming care and engagement for individuals living with Hemophilia through advanced Remote Patient Monitoring technology.
Jan 14, 2025 - New York - Huma today announced a strategic collaboration with Pfizer Inc. (NYSE: PFE) to introduce the Huma Cloud Platform for Hemophilia in the United States. This partnership leverages Huma’s FDA Class 2 510k cleared Remote Patient Monitoring (RPM) solution to provide personalized, data-driven support that enhances patient engagement, adherence to therapy, and communication with healthcare providers—empowering individuals living with Hemophilia and their caregivers.
Bridging gaps in Hemophilia care
Hemophilia patients often face challenges managing complex treatment regimens and accessing specialized care. Huma’s cutting-edge RPM platform, built on the Huma Cloud Platform, delivers a secure, user-friendly experience, combining a patient-focused mobile app with a clinician-facing portal for real-time remote monitoring. Key features include:
Health tracking: Log bleeds, track symptoms, vital signs, and treatment adherence.
Personalized support: Tailored patient education and oversight through nurse navigators.
Enhanced connectivity: Streamlined communication between patients and providers.
The regulatory framework of the platform also lays the groundwork for integrating AI-powered algorithms and clinical decision support tools in the future, driving proactive and efficient care delivery.
Driving digital innovation
The Huma Cloud Platform offers Pfizer and other partners a scalable, no-code, cloud-agnostic framework to rapidly develop and deploy regulated digital solutions for patients with the ability add-on relevant services with ease. By enabling swift, compliant customization across therapeutic areas, it accelerates access to innovative, patient-centric care.
“We are proud to partner with Pfizer to deliver transformative solutions for Hemophilia care,” said Dan Vahdat, CEO and Founder of Huma. “The Huma Cloud Platform reflects our shared vision to empower patients through technology, improving engagement, adherence, and ultimately health outcomes.”
About Huma
Huma is a global healthcare AI company accelerating the adoption of digital solutions for care and research. Huma’s cloud-based platform, trusted by over 4,500 hospitals and clinics globally, is FDA Class II and EU MDR Class IIb cleared, enabling rapid, customizable, and compliant solutions that transform patient outcomes.
Huma media contact
Courtney Obecny
VP of Marketing
401-573-5438